These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective?]. Haberbosch W Herz; 2007 Feb; 32(1):51-7. PubMed ID: 17323035 [TBL] [Abstract][Full Text] [Related]
24. [Rosiglitazone: a clinical development focused on cardio-vascular prevention]. Valensi P Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S35-40. PubMed ID: 12037506 [TBL] [Abstract][Full Text] [Related]
25. Safety of drugs commonly used to treat hypertension, dyslipidemia, and Type 2 diabetes (the metabolic syndrome): part 2. Marcus AO Diabetes Technol Ther; 2000; 2(2):275-81. PubMed ID: 11469270 [TBL] [Abstract][Full Text] [Related]
30. [Dyslipidemia in insulin resistance and its improvement by troglitazone]. Yagi K; Mabuchi H Nihon Rinsho; 2000 Feb; 58(2):426-9. PubMed ID: 10707570 [TBL] [Abstract][Full Text] [Related]
31. A comprehensive review of the antidiabetic agent rosiglitazone. Glazer NB; Cheatham WW Clin Ther; 2001 Feb; 23(2):307-8. PubMed ID: 11293563 [No Abstract] [Full Text] [Related]
32. Marked improvement of glycaemic control with pioglitazone in a Type 2 diabetic patient associated with Charcot-Marie-Tooth disease. Ota T; Osawa K Diabet Med; 2003 May; 20(5):420-1. PubMed ID: 12752495 [No Abstract] [Full Text] [Related]
33. Pioglitazone (Actos). Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011 [No Abstract] [Full Text] [Related]
34. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323 [TBL] [Abstract][Full Text] [Related]
35. Pioglitazone: the future. Brunetti P Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244 [No Abstract] [Full Text] [Related]
36. Synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-substituted aminothiazole-4-yl) phenoxy)-2-methyl propanoic acid derivatives. Mokale SN; Elgire RD; Sakle N; Shinde DB Bioorg Med Chem Lett; 2011 Jan; 21(2):682-5. PubMed ID: 21193309 [TBL] [Abstract][Full Text] [Related]
37. The glitazones: proceed with caution. Krische D West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299 [No Abstract] [Full Text] [Related]
38. New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Hofmann CA; Colca JR Diabetes Care; 1992 Aug; 15(8):1075-8. PubMed ID: 1505314 [No Abstract] [Full Text] [Related]
39. How should patients taking the discontinued diabetes drug troglitazone be managed? Reddy SS Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221 [No Abstract] [Full Text] [Related]